* COSCIENS Biopharma press release [https://seekingalpha.com/pr/20202125-cosciens-biopharma-inc-reports-second-quarter-2025-financial-results-and-provides-strategic] (NASDAQ:CSCI [https://seekingalpha.com/symbol/CSCI]): Q2 GAAP EPS of -$0.75.
* Revenue of $2.7M (+17.4% Y/Y).
* The company had $9.3 million in cash and cash equivalents on June 30, 2025.
MORE ON COSCIENS BIOPHARMA INC.
* Financial information for COSCIENS Biopharma Inc. [https://seekingalpha.com/symbol/CSCI:CA/income-statement]
COSCIENS Biopharma GAAP EPS of -$0.75, revenue of $2.7M
Published 2 months ago
Aug 15, 2025 at 7:06 AM
Neutral
Auto